SEC Form D · Amendment · filed January 10, 2024
LB PHARMACEUTICALS INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (26)
Rebecca Luse · New York, NYDirectorAndrew Vaino · New York, NYExecRan Nussbaum · New York, NYDirectorRobert Ruffolo · New York, NYDirectorZachary Prensky · New York, NYExec · DirectorAnna Eramo · New York, NYExecMarc Panoff · New York, NYExecRajul Jain · New York, NYDirectorMPG Asset Management, LLC · Murphy, TXDirectorRebecca Luse · New York, NYDirectorRei Goffer · Boston, MAExec · DirectorAnna Eramo · New York, NYExecRajul Jain · New York, NYDirectorDean Rosenberg · San Diego, CAExecRan Nussbaum · New York, NYDirectorVincenzo O. Laruffa · New York, NYExecChen Yu · Palo Alto, CADirectorJohn F. Arrillaga Jr · New York, NYExec · DirectorThomas Fortin · New York, NYExecLynne L. Segall · Beverly Hills, CAExecAndrew Chomer · Garrison, NYDirectorAlex Ruggieri · Vancouver, British Columbia, CanadaDirectorRoger Richer · Vancouver, British Columbia, CanadaExecFrancis Macdonald · Vancouver, British Columbia, CanadaDirectorBhavik M. Patel · Miami, FLDirectorChen Yu · Palo Alto, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗